Tuesday, December 05, 2006 8:58:42 AM
d of Advisors ( PrimeNewswire )
B: Valery Zubov, Russian Member of Parliament, Joins NUCON-RF Board of Advisors
PrimeNewswire )
MOSCOW, Dec 5, 2006 (PrimeNewswire via COMTEX) --
NUCON-RF, Inc. (Pink Sheets:NNRF) today said that Professor Valery Zubov,
Ph.D., Member of the Russian Federal Parliament Committee on Credit
Organizations and Financial Markets, has joined the company's Board of
Advisors. Mr. Zubov will counsel the company in the marketing of its nuclear
waste and power quality equipment technologies in the Russian Federation.
Mr. Zubov is recognized as among the most influential figures in the Russian
Parliament's financial sector. A top ranking Deputy of the Duma -- the lower
House of Russian Parliament -- he is primarily responsible for drafting
legislation pertaining to forming more effective financial markets in Russia
and modernizing that nation's banking system. He is also the former Governor
of Russia's Krasnoyarsk Region and one of the founders and deputy director of
that Federal Region's stock exchange.
"We are extremely proud to have Professor Zubov join our Board," said
NUCON-RF Executive Vice President, Peter Goerke. "We anticipate this addition
will help us accelerate our business plan for bringing our cutting edge
technologies to commercialization in many regions of the Russian Federation
and other CIS countries."
NUCON-RF, a U.S. corporation with executive and operations office located in
Moscow and Berlin, is a technical solutions company focused on environmental
markets in the Former Soviet Union, Eastern Europe and Asia. NUCON has the
capability to provide product, technological and engineering support
addressing environmental, power quality and radioactive waste challenges.
These solutions address compliance, shielding, transport and storage
requirements, plant equipment protection, energy efficiency and remediation
techniques for diverse radioactive and toxic wastes. The company possesses
extensive in-house expertise in all aspects of radiological protection and
radiological waste management.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM